Evidence map›Paper›PMID 33932328›Full record

ArticleLancet (London, England)2021

SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties.

Miquel Oliu-Barton, Bary S R Pradelski, Philippe Aghion, Patrick Artus, Ilona Kickbusch, Jeffrey V Lazarus, Devi Sridhar, Samantha Vanderslott

Abstract read
In one paragraph

Article in Lancet (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. COVID-19 and the ecological crisis: What do they have in common?Scandinavian journal of public health · 2023
    Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Miquel Oliu-BartonUniversité Paris Dauphine-PSL, Paris, France; Esade Centre for Economic Policy, Barcelona, Spain.
Bary S R PradelskiFrench National Centre of Scientific Research (CNRS), CS 40700, 38058 Grenoble cedex 9, France; Oxford-Man Institute of Quantitative Finance, University of Oxford, Oxford, UK. Electronic address: bary.pradelski@cnrs.fr.
Philippe AghionCollège de France, Paris, France; London School of Economics and Political Science, London, UK; INSEAD, Fontainebleau, France.
Patrick ArtusNatixis, Paris, France; Paris School of Economics, Paris, France.
Ilona KickbuschGlobal Health Centre, Graduate Institute of International and Development Studies, Geneva, Switzerland.
Jeffrey V LazarusBarcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
Devi SridharGlobal Health Governance Programme, Usher Institute of Population Health Sciences and Informatics and College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK.
Samantha VanderslottOxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Civil RightsCommunicable Disease ControlCOVID-19Gross Domestic ProductHumansPublic HealthSARS-CoV-2

Identifiers

PMID33932328
PMCPMC8081398

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.